Protein engineering and antibody design are central topics on the European biotech calendar in November. PEGS Europe 2026 highlights applications of machine learning, multispecific antibodies and next generation conjugates across its sessions.
Dates and venue in Lisbon
Pegs Europe 2026 runs from 17 to 19 November at the Centro de Congressos de Lisboa. The schedule combines plenary sessions, focused tracks and an extensive poster program mapped to discovery, development and analytical characterisation pathways.
Scientific program and notable speakers
Program tracks cover ML and AI for protein engineering, multispecifics, conjugates, autoimmune biologics and T cell engagers. Confirmed speakers include Jennifer Cochran from Stanford University, Ulrike Philippar from Johnson & Johnson Innovative Medicine, Roland Kontermann from the University of Stuttgart and Patrick Baeuerle from Cullinan Therapeutics.
Key figures for 2026
The organizers list 1,500 attendees and 300 speakers. The event features 20 plenary keynotes, over 50 talks from top biopharma and more than 250 scientific posters.
Types of companies and sector focus
Attending organizations span biotech and pharmaceutical companies engaged in biologics research. The mix includes discovery teams, expression platform providers, analytical specialists and firms developing immunoengineering solutions. Topics on the agenda indicate a strong technical audience focused on antibody engineering and data-driven protein design.
Practical advice for B2B prospecting at Pegs Europe 2026
- Align your outreach to technical tracks relevant to your product, such as ML-driven design or multispecifics.
- Target meetings with discovery leads and technical scientists given the heavy speaker representation from industry.
- Prepare concise technical assets that present performance data and application notes to support scientific conversations.
- Schedule time in the poster area to engage presenters and attendees during breaks and poster sessions.
Closing note and official link
The themes at Pegs Europe 2026 reflect where biologics development is heading, with increasing overlap between computational design and complex modalities. Review program details and sponsorship options at http://www.pegsummiteurope.com to plan participation and meeting logistics.
